Narala was born from a recurring industry problem that needed to be addressed systematically.

When Vish Narayanan joined a rapidly scaling biotech company, he observed a familiar pattern: brilliant science constrained by misaligned technology decisions. The company was advancing promising therapies and attracting investors, but its technology infrastructure was becoming a growth bottleneck.

Without strategic CIO guidance, well-intentioned IT choices created operational inefficiencies. Compliance gaps emerged as regulatory requirements intensified. Critical data lived in silos, slowing decision-making when speed mattered most.

This wasn't unique to one company; it was an industry-wide challenge. Small and mid-sized biotechs often lack the IT leadership necessary to scale from promising research to commercial success. They need the same caliber of strategic technology guidance that large pharmaceutical companies have, but sized appropriately for their stage and budget.

Narala bridges this gap. Since 2019, we have provided stage-appropriate and cost-effective IT solutions that scale with small and medium biotech companies, ensuring that technology amplifies scientific innovation rather than constraining it.

Narala Biotech Services & Solutions

Org chart

Teams

Offices